We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Development and Evaluation of a Tonic Immobility Focused Psychoeducational Intervention (TIP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT05113277
Recruitment Status : Completed
First Posted : November 9, 2021
Last Update Posted : June 16, 2022
Sponsor:
Information provided by (Responsible Party):
Norman Schmidt, Florida State University

Brief Summary:
A randomized controlled trial is planned to evaluate a brief, web-based intervention intended to educate about tonic immobility (TI) within a sample of those who experienced TI in the context of a traumatic event.

Condition or disease Intervention/treatment Phase
Posttraumatic Stress Disorder Tonic Immobility Response Behavioral: Tonic Immobility Psychoeducation (TIP) Behavioral: Health Education Training (HET) Not Applicable

Detailed Description:
A randomized controlled trial is planned to evaluate a brief, web-based intervention intended to educate about tonic immobility (TI) within a sample of those who experienced TI in the context of a traumatic event. The investigators expect that this intervention will lead to improvement in posttraumatic guilt, shame, and PTSD symptoms as compared to an active control condition.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 51 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: Participants will be randomly assigned to complete 1 of 2 interventions - active or control.
Masking: Single (Participant)
Masking Description: The participant will be randomly assigned to the active or control condition. The participant will not be informed of which condition they are receiving until after completion of the study, at which point individuals in the control condition will be given access to the active intervention.
Primary Purpose: Treatment
Official Title: Development and Evaluation of a Tonic Immobility Focused Psychoeducational Intervention - Randomized Controlled Trial (RCT)
Actual Study Start Date : September 27, 2021
Actual Primary Completion Date : March 31, 2022
Actual Study Completion Date : May 31, 2022

Arm Intervention/treatment
Experimental: Tonic Immobility Psychoeducation (TIP)
Participants in the experimental condition will receive the TIP intervention.
Behavioral: Tonic Immobility Psychoeducation (TIP)
TIP is a 45-minute computerized psychoeducation intervention aimed at addressing maladaptive cognitions and emotions associated with TI while using educational and behavioral techniques commonly used in the treatment of trauma-related disorders. Throughout the psychoeducation program vignettes will be presented to clarify concepts and promote participant engagement. In addition, practice exercises and rating scales will be integrated, where applicable, to increase the interactive nature of the program. The following modules will be addressed in the TI psychoeducation intervention: education, myth busting, and behavioral experiments.

Placebo Comparator: Health Education Training (HET)
Participants in the control condition will receive the HET intervention.
Behavioral: Health Education Training (HET)
The Healthy Education Training intervention was developed as a 45-minute online intervention that provides education about physical health habits that can impact mental health, such as diet, exercise, and sleep. This intervention has been used in prior clinical trials to control for effects of general education, general coping techniques, and use of technology. Participants in past clinical trials have reported that HET is engaging and beneficial. However, HET is not expected to have an effect on the main symptom outcomes of the current study (guilt, shame, PTSD symptoms).




Primary Outcome Measures :
  1. Posttraumatic Stress Disorder Symptoms [ Time Frame: up to 1 month ]
    PTSD symptoms measured using the posttraumatic stress checklist for DSM-5 (PCL-5); Value range = 0 to 80 with lower values indicating better outcomes.

  2. Guilt [ Time Frame: up to 1 month ]
    Feelings of guilt as measured using the state shame-guilt scale, 8-item (SSGS-8); Value range = 5 to 20 with lower values indicating better outcomes.

  3. Shame [ Time Frame: up to 1 month ]
    Feelings of shame as measured using the state shame-guilt scale, 8-item (SSGS-8); Value range = 5 to 20 with lower values indicating better outcomes.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • 18 years or older
  • Endorsed prior TI experience (TIQ items A & B)
  • Elevated posttraumatic stress symptoms (PCL-5; Blevins et al., 2015)

Exclusion Criteria:

Inability to consent or complete the intervention including:

  • Cognitive impairment
  • Uncorrected visual or auditory impairment
  • Unmedicated severe mental illness
  • Imminent risk of harm to self or others

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05113277


Locations
Layout table for location information
United States, Florida
Anxiety and Behavioral Health Clinic
Tallahassee, Florida, United States, 32306
Sponsors and Collaborators
Florida State University
Investigators
Layout table for investigator information
Principal Investigator: Norman B Schmidt, PhD Florida State University
Layout table for additonal information
Responsible Party: Norman Schmidt, Distinguished Research Professor, Florida State University
ClinicalTrials.gov Identifier: NCT05113277    
Other Study ID Numbers: Morabito01
First Posted: November 9, 2021    Key Record Dates
Last Update Posted: June 16, 2022
Last Verified: June 2022

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Norman Schmidt, Florida State University:
Psychoeducation
Online Intervention
Additional relevant MeSH terms:
Layout table for MeSH terms
Stress Disorders, Post-Traumatic
Stress Disorders, Traumatic
Trauma and Stressor Related Disorders
Mental Disorders